BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2185055)

  • 1. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
    Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Hermans MP; Brichard SM; Colin I; Borgies P; Ketelslegers JM; Lambert AE
    Am J Med; 1992 Apr; 92(4B):102S-107S. PubMed ID: 1580274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function, glycaemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():57-61. PubMed ID: 2505714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
    Sano T; Kawamura T; Matsumae H; Sasaki H; Nakayama M; Hara T; Matsuo S; Hotta N; Sakamoto N
    Diabetes Care; 1994 May; 17(5):420-4. PubMed ID: 8062609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Vilarrasa N; Soler J; Montanya E
    Acta Diabetol; 2005 Jun; 42(2):87-94. PubMed ID: 15944842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
    Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M
    Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
    Jandrain B; Herbaut C; Depoorter JC; Voorde KV
    Am J Med; 1992 Apr; 92(4B):91S-94S. PubMed ID: 1580288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
    Trevisan R; Tiengo A
    Am J Hypertens; 1995 Sep; 8(9):876-83. PubMed ID: 8541002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of perindopril in treatment of early diabetic nephropathy with normal blood pressure and microalbuminuria].
    Yao B; Hu G; Li Y; Liao Z; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):826-8. PubMed ID: 16206673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P; Bilbous R; Mitchell T; O' Callaghan CJ; Viberti GC;
    Diabetes Care; 2000 Dec; 23(12):1823-9. PubMed ID: 11128360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.
    Harmankaya O; Seber S; Yilmaz M
    Ren Fail; 2003 May; 25(3):465-70. PubMed ID: 12803510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.